The GOLD Podcast: Weekly Pharma Insights

This GOLD Nugget episode sees Helena reflect on some of the best insights offered by Pav Rishiraj, Director and Head of Pharmacovigilance at Ipsen. She shares some of Pav's thoughts on how the often under-recognised field of pharmacovigilance has changed – particularly its rapid evolution during the COVID-19 pandemic – and its importance as a strategic enabler, as well as Pav's advice on what pharma should do to ensure teams feel valued and integral to the businesses they serve.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Pav’s full episode: Pharmacovigilance past, present and future https://www.emg-gold.com/post/podcast-pharmacovigilance-past-present-and-future

The physics of pharmacovigilance https://www.emg-gold.com/post/the-physics-of-pharmacovigilance

In the second of four special bonus episodes, Helena looks back at GOLD’s conversation with Paul Simms, CEO, Impatient Health. She considers some of the gold nuggets that Paul shared, including insights on the current state of pharma’s reputation and the ways in which pharma can recover and bolster its reputation.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Paul’s full episode: Unpicking pharma’s reputation in pop culture https://www.emg-gold.com/post/podcast-unpicking-pharma-s-reputation-in-pop-culture

Reframing Pharma’s bad boy reputation https://www.emg-gold.com/post/reframing-pharma-s-bad-boy-reputation

Hear more from Paul:

Is the pharma rep at death's door? https://www.emg-gold.com/post/is-the-pharma-rep-at-death-s-door

The reality of the metaverse https://www.emg-gold.com/post/the-reality-of-the-metaverse

In the first of four special bonus episodes, Helena looks back at the launch episode of Season 3, which featured Dr Juby Jacob-Nara, Vice President and Global Medical Head for Respiratory, Allergy and Gastro-Intestinal Diseases, Sanofi. Helena considers some of the gold nuggets that Juby shared, including insights on the importance of cross-functional experience, team diversity and continual learning.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Juby’s full episode: Meet GOLD’s new catalyst – medical aficionado Juby Jacob-Nara https://www.emg-gold.com/post/podcast-meet-gold-s-new-catalyst-medical-aficionado-juby-jacob-nara

Catalyst interview: Juby Jacob-Nara on medical affairs https://www.emg-gold.com/post/juby-jacob-nara-on-medical-affairs

Revealing the true value of medical affairs https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs

Preparing MSLs for the spotlight https://www.emg-gold.com/post/preparing-msls-for-the-spotlight

This week’s season finale episode welcomes back some friends of the podcast – most of whom we interviewed on the show this year – to reflect on the past 12 months and give us their take on their key highlights. Hear Aliya Omer, Claire Gillis, Robert Grimm, Michele Manto, Paul Simms and Wendy White, unravel the past year in pharma, looking at everything from access challenges to organisational change to huge wins for marketing approaches and sharing some fascinating insights.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

The impact of global instability https://www.emg-gold.com/_files/ugd/b8a9db_a8c25d06ae954bb98e0fa3448f259168.pdf

Behind the headlines of the Inflation Reduction Act https://www.emg-gold.com/post/behind-the-headlines-of-the-inflation-reduction-act

Revealing the true value of medical affairs https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs

Embracing pharma's digital transformation https://www.emg-gold.com/post/embracing-pharma-s-digital-transformation

Elevating pharma’s parental leave policies https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies

This week on the podcast, GOLD discusses the field of pharma sales with James Harper, Founder and Managing Director, twentyeightb. James shares his story of joining the pharma industry, the incredible importance of striving to add value to every customer engagement, whether MSLs and sales reps could ever converge and the priority of mindset over toolset. All this stems from the inaugural event from James’ new initiative ‘Digital Pharma: Unlocked’ – a group aiming to help the pharma industry see digital as a positive enablement tool.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

Is the pharma rep at death's door? https://www.emg-gold.com/post/is-the-pharma-rep-at-death-s-door 

Revealing the true value of medical affairs https://www.emg-gold.com/post/revealing-the-true-value-of-medical-affairs 

A Field Force for the Future https://www.emg-gold.com/post/a-field-force-for-the-future 

Alexander Natz on pricing and access https://www.emg-gold.com/post/podcast-pharma-in-south-africa-access-pricing-and-reimbursement

In this week’s episode, Helena and Isabel share an interview with GOLD’s new catalyst John Wahba, Medical Head of the Global Digital Hub, GSK. In this teaser edition of the catalyst interview, John shares his motivations for joining the pharmaceutical industry, key takeaways from his time in the medical field, thoughts on digitally optimising MSL teams and much more. If you want to read the written interview in full, check out the link below. 

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• John Wahba on the medical affairs evolution
• Pharma in Japan 
• Urgent need to boost trade for UK's life sciences, says ABPI

This week, the GOLD team presents a special episode to mark World AIDS Day, which is taking place on 1st December. Hear from Dr Nneka Nwokolo, Global Head of Patient Affairs, ViiV Healthcare, and Claire Gillis, CEO, VMLY&R Health, as they both discuss HIV stigma, prevention and care in the world today and how pharma can support healthcare professionals and patients. GOLD also speaks to former guest, Laurence Woollard, Director, On the Pulse Consultancy, and haemophilia patient advocate, to get his verdict on the new approval of a first-of-its-kind gene therapy for haemophilia B.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Access win for HIV patients in sub-Saharan Africa https://www.emg-gold.com/post/access-win-for-hiv-patients-in-sub-saharan-africa
• Monkeypox, misinformation and mitigating a pandemic https://www.emg-gold.com/post/monkeypox-misinformation-and-mitigating-a-pandemic
• Building campaigns with communities https://www.emg-gold.com/post/building-campaigns-with-communities
• Laurence Woollard on challenges facing the haemophilia community https://www.emg-gold.com/post/podcast-digital-solutions-cell-and-gene-therapy-and-haemophilia-in-focus

This week, GOLD chats to Silvia Taylor, Executive Vice President and Chief Communications Officer, Novavax. She reveals what it was like to join Novavax at the height of the pandemic, the importance of storytelling to ensure uptake and access to new vaccines and the advice she would give her younger self on how to succeed. If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Pharma's sustainability agenda centre stage in new ABPI report https://www.emg-gold.com/post/pharma-s-sustainability-agenda-centre-stage-in-new-abpi-report
• 2022 Access to Medicine Index reveals improvement https://www.emg-gold.com/post/2022-access-to-medicine-index-reveals-improvement
• Keeping the spark alive in vaccine development https://www.emg-gold.com/post/keeping-the-spark-alive-in-vaccine-development
• How to enhance value and access across pharma https://www.emg-gold.com/post/podcast-how-to-enhance-value-and-access-across-pharma

This week, the GOLD team shares a conversation with Christoph Glaetzer, Chief Global Value and Access Officer, Johnson & Johnson. He discusses his lengthy career within value and access and his drive to enter the industry, his proudest achievements while working at J&J and the importance of having a good leader to learn from. And in news you might have missed, the team showcases some recent investment in the psychedelics market, a first-in-10-years paediatric vaccine and a new study investigating the prevalence of undiagnosed CKD.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Behind the headlines of the inflation reduction act https://www.emg-gold.com/post/behind-the-headlines-of-the-inflation-reduction-act

Pharma in South Africa, access, pricing and reimbursement https://www.emg-gold.com/post/podcast-pharma-in-south-africa-access-pricing-and-reimbursement

Margo Warren on global access to medicine https://www.emg-gold.com/post/podcast-margo-warren-on-global-access-to-medicine

In this week’s episode, GOLD speaks to Eugene Borukhovich, Co-Founder and COO, YourCoach.Health, about the evolving landscape of digital therapeutics. He discusses his journey into the pharmaceutical space, tips for companies looking to get into DTx and his predictions for this tech evolution over coming years. And news you might have missed showcases collaborative efforts against ebola and good news from Gilead Sciences.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

The changing rhythm of digital therapeutics https://www.emg-gold.com/post/the-changing-rhythm-of-digital-therapeutics

Embracing pharma’s digital transformation https://www.emg-gold.com/post/embracing-pharma-s-digital-transformation

Top tips for digital innovation and the future of patient centricity https://www.emg-gold.com/post/podcast-top-tips-for-digital-innovation-and-the-future-of-patient-centricity

This week, the GOLD team discusses key articles and themes from the latest magazine, drilling down into topics such as what pharma can learn from the tech giants, the industry’s response to Roe v. Wade and the delicate balance of biotech success, to give listeners some exclusive context and insights on three fascinating stories affecting the industry today.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Following in the footsteps of tech giants https://www.emg-gold.com/post/following-in-the-footsteps-of-tech-giants

Pharma’s response to Roe v. Wade https://www.emg-gold.com/post/pharma-s-response-to-roe-v-wade

Is the biotech boom on thin ice? https://www.emg-gold.com/post/is-the-biotech-boom-on-thin-ice

Decentralised clinical trials: going green https://www.emg-gold.com/post/decentralised-clinical-trials-going-green

In this week’s episode, GOLD speaks to Patrick Short, CEO, Sano Genetics, about the challenges and opportunities in genetic medicine today. He discusses his personal connection to tackling genetic diseases, the top reasons behind research participation hesitancy and the therapy areas in which he believes genomic testing and medicine could be most impactful. Plus, news from the World Health Summit.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

• Tackling the trust gap in genomic medicine https://www.emg-gold.com/post/tackling-the-trust-gap-in-genomic-medicine
• The rare disease disparity https://www.emg-gold.com/post/the-rare-disease-disparity
• Davidek Herron on embracing pharma's digital transformation https://www.emg-gold.com/post/embracing-pharma-s-digital-transformation

In this week’s episode, Helena and Isabel share an interview with GOLD’s next Catalyst Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology. In this special extended version of the interview exclusive to the podcast, hear Reshema’s story and insights in full, including the life experiences that have led her to where she is today, her ideas for tackling clinical trial recruitment gaps, why equal representation matters and so much more.  

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content: 

• Ripples of change in R&D https://www.emg-gold.com/post/ripples-of-change-in-research-and-development 

• Setting the stage for a more equitable future https://www.emg-gold.com/post/setting-the-stage-for-a-more-equitable-future 
• Previous Catalyst interview with Juby Jacob-Nara https://www.emg-gold.com/post/juby-jacob-nara-on-medical-affairs

In this week’s episode, Helena is joined by Paul Simms, CEO of Impatient Health, to delve deeper into GOLD’s recent cover feature on reframing pharma’s bad boy reputation. They chat about the current state of pharma’s reputation and the influence of the media and pop culture on this, the ways in which pharma can recover and bolster its reputation, and more. And in ‘news you might have missed’, Helena discusses the latest global awareness campaign from Leo Pharma, the ABPI’s recent survey on pharma and academia collaboration and a new Marvel comic strip features Pfizer’s COVID-19 vaccination efforts in the US.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Reframing pharma's bad boy reputation https://www.emg-gold.com/post/reframing-pharma-s-bad-boy-reputation

Talking to Paul Simms https://www.emg-gold.com/post/podcast-talking-to-paul-simms  

[Yesterday 15:46] Helena Beer

Top tips for digital innovation and the future of patient centricity

In this week’s episode of The GOLD Podcast, Helena is joined by Konrad Dobschuetz, National Director at NHS Innovation Accelerator and Chief Enterprise Officer at UCL Partners, who discusses all things digital innovation. They chat about his transition from the fashion industry to pharma, some digital innovation top tips for companies and his new role at the NHS and the importance of collaboration, plus his take on how the humble automobile may someday turn into a diagnostic tool. And in ‘news you might have missed’, Helena discusses the latest from Boehringer Ingelheim, Sanofi and GSK.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Meet GOLD's catalyst - digital innovator, Davidek Herron: https://www.emg-gold.com/post/podcast-catalyst-digital-innovator-davidek-herron

Digitalisation: moving past paperless: https://www.emg-gold.com/post/digitalisation-moving-past-paperless

Reframing pharma's bad boy reputation https://www.emg-gold.com/post/reframing-pharma-s-bad-boy-reputation

Taking a bet on blockchain https://www.emg-gold.com/post/taking-a-bet-on-blockchain

This week’s episode features a fascinating conversation with Samin Saeed, UK Chief Scientific Officer and Medical Director at Novartis UK. She discusses a whole host of medical affairs-related issues, including the transition from medicine to pharma, cross-functionality, commercial versus medical affairs, and lots more besides, including a fascinating discussion about leadership, company culture and soft skills development. And ‘news you might have missed’ focuses on the European life sciences gender pay gap and new investment for Novartis.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Preparing MSLs for the spotlight https://www.emg-gold.com/post/preparing-msls-for-the-spotlight

Juby Jacob-Nara on medical affairs https://www.emg-gold.com/post/juby-jacob-nara-on-medical-affairs

Aliya Omer on gender equality https://www.emg-gold.com/post/podcast-aliya-omer-on-gender-equality

Reframing pharma’s bad boy reputation https://www.emg-gold.com/post/reframing-pharma-s-bad-boy-reputation

Elevating pharma’s parental leave policies https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies

This week, Marc and Helena are joined in the podcast studio by Pav Rishiraj, Director and Head of Pharmacovigilance at Ipsen, to shed some light on this often-overlooked field of pharma. He discusses his career journey in pharmacovigilance and how, in his experience, the field has changed; the importance of pharmacovigilance as a strategic enabler within businesses; and the outlook for the future of the field in terms of AI and automation. Helena also leads a short tribute to Her Majesty Queen Elizabeth II.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

The physics of pharmacovigilance https://www.emg-gold.com/post/the-physics-of-pharmacovigilance

RWE, the metrics of medical affairs and TikTok marketing https://www.emg-gold.com/post/podcast-real-world-evidence-the-metrics-of-medical-affairs-and-tiktok-marketing

It's good to be back! To celebrate the launch of Season 3 of The GOLD Podcast, Marc and Helena bring you a special extended version of our conversation with GOLD’s latest catalyst interviewee Dr Juby Jacob-Nara, Vice President and Global Medical Head for Respiratory, Allergy and Gastro-Intestinal Diseases, Sanofi. She speaks to Assistant Editor Isabel O’Brien about her move from medicine to medical affairs, her passion for cross-functional learning and how former physicians can empower themselves to succeed in the pharmaceutical industry.  

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Dr Juby Jacob-Nara on making it medical affairs https://www.emg-gold.com/post/juby-jacob-nara-on-medical-affairs

Preparing MSLs for the spotlight https://www.emg-gold.com/post/preparing-msls-for-the-spotlight

Luca Dezzani and Luisa Luciani-Silverman on medical affairs https://www.emg-gold.com/post/podcast-luca-dezzani-and-luisa-luciani-silverman-on-medical-affairs

Medical affairs evolution and the future for MSLs https://www.emg-gold.com/post/podcast-medical-affairs-evolution-and-the-future-for-msls

RWE, the metrics of medical affairs and TikTok marketing https://www.emg-gold.com/post/podcast-real-world-evidence-the-metrics-of-medical-affairs-and-tiktok-marketing

For our fifth and final GOLD Nugget of season 2, Helena looks back to one of our most popular episodes featuring Davidek Herron, Global Head of Digital at Roche. In these snippets, Davidek gives some great insights into what digital transformation means to him, drawing upon his time playing professional basketball in New York to illustrate his move into the pharma industry and some tips on learning from failure.

If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:

Davidek’s full episode: https://www.emg-gold.com/post/podcast-catalyst-digital-innovator-davidek-herron

Davidek Herron on digital transformation: https://www.emg-gold.com/post/davidek-herron-on-digital-transformation

Bridging the digital health divide: https://www.emg-gold.com/post/bridging-the-digital-health-divide